1. Ireland Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Kneat.com, Inc.

Kneat.com, Inc.

KSI.TO
Kneat.com, Inc.CA flagToronto Stock Exchange
6.47
CAD
- -
- -
621.97MMarket Cap
Kneat.com, Inc.
KSI.TO
(Toronto Stock Exchange)

Recent

price

6.47

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
0.04
- -
0.01
0.03
0.07
0.11
0.21
0.31
0.44
0.57
0.67
0.7
Revenue per Share
-1.52
-0.06
-0.04
-0.03
-0.09
-0.09
-0.11
-0.09
-0.13
-0.12
-0.19
-0.09
-0.02
-0.09
Basic EPS, GAAP
-0.03
-0.04
-0.07
-0.15
-0.12
-0.14
-0.12
-0.14
-0.1
-0.13
-0.24
-0.12
-0.1
-0.21
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
0.01
0.06
0.82
0.12
0.12
0.14
0.25
0.4
0.29
0.11
0.68
0.66
0.64
Book Value per Share
0.57
-0.02
0.02
0.69
0.07
0.06
0.09
0.15
0.28
0.09
-0.17
0.33
0.2
0.18
Tangible Book Value per Share
26
27
26
19
43
50
59
66
74
77
78
87
95
95
Basic Weighted Avg Shares
- -
- -
1
- -
- -
1
4
7
16
24
34
49
63
67
Sales/Revenue/Turnover
- -
- -
-99.55
- -
-1,016.42
-395.36
-128.78
-88.35
-40.99
-41.16
-40.72
-12.15
-13.35
-14.09
Operating Margin (%)
- -
- -
1
- -
1
2
2
3
4
6
8
10
14
15
Depreciation Expense
-40
-2
-1
-1
-4
-5
-6
-6
-10
-9
-15
-8
-2
-8
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
-102.32
- -
-948.31
-352.52
-156.88
-76.68
-63.6
-38.52
-42.43
-15.79
-3.71
-12.69
Profit Margin (%)
1
- -
1
- -
3
2
4
7
18
5
6
44
30
24
Working Capital
- -
1
1
1
1
- -
1
9
7
7
28
25
21
18
LT Debt
15
1
2
15
7
8
11
19
34
26
16
65
65
63
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-1,840.16
-113.17
-5.97
-39.28
-82.8
-86.02
-46.04
-42.65
-35.19
-94.93
-22.98
-3.87
-13.68
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
7
8
9
LT Borrowings
16
14
12
LT Finance Leases
7
7
6
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
95
96
96
Market Capitalization
560
467
333

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
73
66
81
Cash, Cash Equivalents & STI
60
49
52
Accounts Receivable, Net
8
7
23
Inventories
- -
- -
- -
Total Current Liabilities
43
36
57
Payables & Accruals
9
8
7
ST Debt
7
8
9
Deferred Revenue
25
19
39

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
98%
63.89%
-0.08%
Free Cash Flow
26.19%
9.85%
-3.21%
Net Income, GAAP
69.42%
1.67%
-69.61%
Sales/Revenue/Turnover
- -
55.69%
29.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
11
12
13
14
49
2025
15
15
16
17
63
2026
18
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.04
-0.04
0.01
- -
-0.09
2025
0.02
- -
-0.01
-0.04
-0.02
2026
-0.04
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
EUDA Health Holdings Limited (EUDA)
Certive Solutions Inc. (CBP.CN)
CareMax, Inc. (CMAXW)
Apptly Health Technologies Corp. (ESVNF)
GENOVA, Inc. (9341.T)
Beamtree Holdings Limited (BMT.AX)
Business
Kneat.com, Inc. (TSX: KSI) designs, develops and supplies configurable digital validation software and related professional services for data and document management in highly regulated industries, primarily life sciences including biotechnology, pharmaceuticals, medical devices and consumer health; the company offers its core Kneat Gx cloud-based platform, which supports validation lifecycle management across applications such as commissioning and qualification, computer system validation, equipment validation, analytical instrument qualification, process validation, cleaning validation, method validation, cold chain validation, electronic logbook management, utility and facility validation and drawing management; Kneat Gx provides no-code workflow configuration, full traceability, 21 CFR Part 11 and Annex 11 compliance, real-time audit readiness and integrations with enterprise systems like ERP, QMS and DMS; Kneat also delivers professional services encompassing consulting, training, process mapping and optimization, project management, data migration, custom integrations, analytics and technical account management. Kneat.com, Inc., founded in 2007 with global headquarters in Limerick, Ireland and Canadian legal domicile in Ottawa, Ontario, operates across North America, Europe and Asia Pacific, serving eight of the world's ten largest biopharma companies and other clients such as Biogen, Merck Sharp & Dohme, Takeda, Recipharm, Sanofi and ElevateBio. In 2024, the company achieved record Q4 revenue of $13.7 million (up 40% year-over-year) and full-year SaaS revenue growth of 41%, added five major strategic customers including a consumer products company, critical care company, pharmaceutical firm, CDMO and medical device maker, and formalized partnerships with Körber and ALTEN Group; in January 2025, Kneat partnered with Capgemini for enterprise-wide Kneat Gx deployments and system integrations, while signaling continued SaaS momentum, AI and R&D expansion, and a 20-30% EBITDA margin target.

Company News

APIChatGPT